Statins Market to 2018 New Report
Statins Market to 2018 - Weak Product Pipeline and Shift of Focus towards Combination Therapies will Lead to Erosion of Brand Share, forecasts the worldwide statins market to drop from a 2012 valuation of US$19.7 billion to US$12.2 billion just five years later at a negative Compound Annual Growth Rate (CAGR) of 7.7%.
View full press release